文献速递肝胆胰外科围术期管理与 ERAS

门静脉高压围术期管理后肝细胞癌肝切除术的结局

Hepatectomy for hepatocellular carcinoma after perioperative management of portal hypertension.
PubMed 文献 · Br J Surg · 2019-04-16

这项单中心回顾性研究纳入1994至2015年1259例因肝细胞癌行肝切除术的患者,比较接受门静脉高压围术期预防性管理(PPM)、有门静脉高压未接受PPM及无门静脉高压三组的短期与长期结局。结果显示PPM组与未PPM组总体生存无显著差异,但PPM组生存优于无门静脉高压组以外对比需谨慎;结论认为对门静脉高压患者进行适当管理后肝切除术结局可接受。

核心结论

  • 在亚洲人群中,对门静脉高压进行适当围术期管理的肝细胞癌患者接受肝切除术可获得可接受的结局。
  • 通过PPM提高肝切除安全性可能为扩大门静脉高压患者肝切除指征提供依据。

研究设计与样本

  • 单中心回顾性研究,纳入1994至2015年连续因肝细胞癌行肝切除术的患者1259例。
  • 患者分为三组:接受PPM的门静脉高压组123例、有门静脉高压未接受PPM组181例、无门静脉高压组955例。

临床怎么用

  • 对合并门静脉高压的肝细胞癌患者,可考虑在围术期实施预防性管理以降低肝切除风险。
  • 门静脉高压不应被视为肝切除术的绝对禁忌,但需权衡其仍低于无门静脉高压患者的长期生存。

局限性

  • 为单中心回顾性研究,存在选择偏倚可能。
  • PPM的具体方案及门静脉高压定义未在摘要中详述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Indications for hepatectomy in patients with hepatocellular carcinoma (HCC) who have portal hypertension (PH) have been controversial. Some studies have concluded that PH is a contraindication to hepatectomy, whereas others have suggested that perioperative prophylactic management (PPM) can help overcome complications after hepatectomy associated with PH. The objective of this retrospective study was to assess the short- and long-term outcomes after hepatectomy for HCC in patients with PH, with or without PPM. METHODS: Records were reviewed of consecutive patients who underwent hepatectomy for HCC, with or without PPM of PH, in a single institution from 1994 to 2015. Patients were divided into three groups: those who received PPM for PH (PPM group), patients who had PH but did not receive PPM (no-PPM group) and those without PH (no-PH group). RESULTS: A total of 1259 patients were enrolled, including 123 in the PPM group, 181 in the no-PPM group and 955 in the no-PH group. Three- and 5-year overall survival rates were 74·3 and 53·1 per cent respectively in the PPM group, 69·2 and 54·9 per cent in the no-PPM group, and 78·1 and 64·2 per cent in the no-PH group (P = 0·520 for PPM versus no PPM, P = 0·027 for PPM versus no PH, and P < 0·001 for no PPM versus no PH). Postoperative morbidity and mortality rates were 26·0 and 0·8 per cent respectively in the PPM group, 29·8 and 1·1 per cent in the no-PPM group, and 20·3 and 0 per cent in the no-PH group. CONCLUSION: The present study has demonstrated acceptable outcomes among patients with HCC who received appropriate management for PH in an Asian population. Enhancement of the safety of hepatic resection through use of PPM may provide a rationale for expansion of indications for hepatectomy in patients with PH.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Takemura N, Aoki T, Hasegawa K, et al. Hepatectomy for hepatocellular carcinoma after perioperative management of portal hypertension. Br J Surg. 2019. PMID: 30990885. doi:10.1002/bjs.11153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。